16-1210360-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_021098.3(CACNA1H):​c.3846-10G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 0 hom., cov: 0)
Exomes 𝑓: 0.23 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CACNA1H
NM_021098.3 intron

Scores

2
Splicing: ADA: 0.00001511
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.79

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-1210360-G-C is Benign according to our data. Variant chr16-1210360-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 706988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.3846-10G>C
intron
N/ANP_066921.2
CACNA1H
NM_001005407.2
c.3846-10G>C
intron
N/ANP_001005407.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.3846-10G>C
intron
N/AENSP00000334198.7
CACNA1H
ENST00000569107.6
TSL:1
c.3846-10G>C
intron
N/AENSP00000454990.2
CACNA1H
ENST00000711493.1
c.3846-10G>C
intron
N/AENSP00000518778.1

Frequencies

GnomAD3 genomes
AF:
0.152
AC:
1643
AN:
10774
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.148
Gnomad AMI
AF:
0.214
Gnomad AMR
AF:
0.0666
Gnomad ASJ
AF:
0.216
Gnomad EAS
AF:
0.0455
Gnomad SAS
AF:
0.0738
Gnomad FIN
AF:
0.143
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.198
Gnomad OTH
AF:
0.181
GnomAD2 exomes
AF:
0.239
AC:
9576
AN:
40034
AF XY:
0.234
show subpopulations
Gnomad AFR exome
AF:
0.197
Gnomad AMR exome
AF:
0.401
Gnomad ASJ exome
AF:
0.237
Gnomad EAS exome
AF:
0.337
Gnomad FIN exome
AF:
0.175
Gnomad NFE exome
AF:
0.201
Gnomad OTH exome
AF:
0.287
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.225
AC:
25156
AN:
111784
Hom.:
0
Cov.:
0
AF XY:
0.226
AC XY:
13637
AN XY:
60390
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.273
AC:
899
AN:
3290
American (AMR)
AF:
0.348
AC:
2637
AN:
7576
Ashkenazi Jewish (ASJ)
AF:
0.204
AC:
714
AN:
3492
East Asian (EAS)
AF:
0.190
AC:
715
AN:
3768
South Asian (SAS)
AF:
0.273
AC:
4295
AN:
15712
European-Finnish (FIN)
AF:
0.170
AC:
777
AN:
4558
Middle Eastern (MID)
AF:
0.0941
AC:
76
AN:
808
European-Non Finnish (NFE)
AF:
0.205
AC:
13904
AN:
67708
Other (OTH)
AF:
0.234
AC:
1139
AN:
4872
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.331
Heterozygous variant carriers
0
1433
2866
4299
5732
7165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.152
AC:
1644
AN:
10828
Hom.:
0
Cov.:
0
AF XY:
0.134
AC XY:
776
AN XY:
5798
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.146
AC:
435
AN:
2978
American (AMR)
AF:
0.0663
AC:
111
AN:
1674
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
38
AN:
176
East Asian (EAS)
AF:
0.0455
AC:
12
AN:
264
South Asian (SAS)
AF:
0.0732
AC:
18
AN:
246
European-Finnish (FIN)
AF:
0.143
AC:
129
AN:
900
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
18
European-Non Finnish (NFE)
AF:
0.198
AC:
857
AN:
4334
Other (OTH)
AF:
0.181
AC:
38
AN:
210
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.284
Heterozygous variant carriers
0
134
268
401
535
669
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000246
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 20, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.0
DANN
Benign
0.36
PhyloP100
-2.8
PromoterAI
0.018
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000015
dbscSNV1_RF
Benign
0.022
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377030217; hg19: chr16-1260360; API